4.6 Article

Recurrence of chronic subdural hematoma due to low-grade infection

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Clinical Neurology

Steroid in Chronic Subdural Hematoma: An Updated Systematic Review and Meta-Analysis Post DEX-CSDH Trial

Dhan Bahadur Shrestha et al.

Summary: The study found that treatment with steroids was associated with a lower recurrence rate of CSDH. However, there was no advantage of steroid treatment over nonsteroid treatment in terms of mortality and treatment success, and there was a significantly increased risk of adverse events.

WORLD NEUROSURGERY (2022)

Article Surgery

Rigid Neuroendoscopy Assisted Hematoma Resection Reduces the Recurrence Rate of Chronic Subdural Hematoma With Mixed Density: A Retrospective Analytic Cohort Study

Huangyi Fang et al.

Summary: Compared with traditional burr-hole craniostomy, rigid neuroendoscopy assisted hematoma resection can better reduce the recurrence rate of chronic subdural hematoma with mixed density. It also outperforms burr-hole craniostomy in reducing pneumocephalus volume, improving hematoma evacuation rate, promoting short-term neurological recovery, and shortening hospital stays.

FRONTIERS IN SURGERY (2022)

Article Clinical Neurology

Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: A Multi-Center Experience of 154 Consecutive Embolizations

Peter Kan et al.

Summary: MMA embolization has shown promising results in treating chronic subdural hematoma, with high safety and efficacy rates. Most patients experienced a significant reduction in hematoma thickness during follow-up, indicating a successful clinical outcome.

NEUROSURGERY (2021)

Review Critical Care Medicine

Paradigms in chronic subdural hematoma pathophysiology: Current treatments and new directions

Michael T. Bounajem et al.

Summary: Chronic subdural hematomas have high recurrence rates due to a complex inflammatory response, involving proinflammatory mediators like vascular endothelial growth factor and interleukins. Current treatments such as subdural evacuation may not fully address these pathological factors, requiring targeted approaches like middle meningeal artery embolization and anti-inflammatory therapies for improved efficacy.

JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2021)

Article Infectious Diseases

Unusual subdural empyema in a homeless patient diagnosed by molecular approach: a case report

Cecile Brin et al.

BMC INFECTIOUS DISEASES (2020)

Article Critical Care Medicine

Expression of Angiopoietins and Angiogenic Signaling Pathway Molecules in Chronic Subdural Hematomas

Taiki Isaji et al.

JOURNAL OF NEUROTRAUMA (2020)

Article Medicine, General & Internal

Trial of Dexamethasone for Chronic Subdural Hematoma

Peter J. Hutchinson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Clinical Neurology

Chronic Subdural Hematoma: Epidemiology and Natural History

Wuyang Yang et al.

NEUROSURGERY CLINICS OF NORTH AMERICA (2017)

Review Clinical Neurology

Chronic Subdural Hematoma: A Historical and Clinical Perspective

Ronald Sahyouni et al.

WORLD NEUROSURGERY (2017)

Article Clinical Neurology

Review of the Management of Infected Subdural Hematoma

Carlos B. Dabdoub et al.

WORLD NEUROSURGERY (2016)

Article Clinical Neurology

Effect of Inner Membrane Tearing in the Treatment of Adult Chronic Subdural Hematoma: A Comparative Study

Selim Kayaci et al.

NEUROLOGIA MEDICO-CHIRURGICA (2014)